Oxyprim

N/A

Report date: 2023/04/23 15:29:27
NME

Base Information

Drug NameOxyprim
Drug Alias NameB AN)OxyprimOxipurinol (Rec INN)AlloxanthineOxypurinol (USAN +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsHeart FailureStomatitisGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanz Pharma CorpGenzyme CorpNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsN/A
Inactive IndicationsHeart FailureStomatitisGout

Other Information

ATC CodeN/A
Related LinksN/A